OverviewSuggest Edit

MDxHealth is a molecular diagnostics company that develops and commercializes advanced tests for cancer assessment and the personalized treatment of patients. Applying our patented DNA methylation platform and biomarkers, we help address a large and growing unmet medical need for better cancer diagnosis and treatment information. MDxHealth is a publicly-listed company trading on the NYSE Euronext (NYSE as in New York Stock Exchange) markets of Brussels and Amsterdam under the ticker symbol "MDXH". MDxHealth (formerly OncoMethylome Sciences) was established in 2003 and is headquartered in Belgium. Its US headquarters is located in Durham, NC. MDxHealth develops molecular diagnostic products on its own or in partnership with pharmaceutical companies. Some of its products are already commercialized and the company has a broad pipeline of other products for major cancer indications.
TypePublic
Founded2004
HQHerstal, BE
Websitemdxhealth.com
Employee Ratings3.1

Latest Updates

Employees (est.) (Dec 2020)177
Share Price (Jan 2021)€1 (-2%)
Cybersecurity ratingCMore

Key People/Management at MDxHealth

Michael K. McGarrity

Michael K. McGarrity

Chief Executive Officer
Koen Hoffman

Koen Hoffman

Director
Joseph Sollee

Joseph Sollee

Executive Vice President of Corporate Development and General Counsel
Jean-Marc Roelandt

Jean-Marc Roelandt

CFO
Walter Narajowski

Walter Narajowski

Director
Rudi Mariën

Rudi Mariën

Director
Show more

MDxHealth Office Locations

MDxHealth has offices in Herstal, Irvine and Nijmegen
Herstal, BE (HQ)
31 Rue d'Abhooz
Nijmegen, NL
Transistorweg 7
Irvine, CA, US
15279 Alton Pkwy #100
Show all (3)

MDxHealth Financials and Metrics

MDxHealth Revenue

Market capitalization (19-Jan-2021)

89.8m

Closing stock price (19-Jan-2021)

1.0
MDxHealth's current market capitalization is €89.8 m.
Show all financial metrics

MDxHealth Cybersecurity Score

Cybersecurity ratingPremium dataset

C

73/100

SecurityScorecard logo

MDxHealth Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

30-39

out of 100

CSRHub logo

MDxHealth Online and Social Media Presence

Embed Graph

MDxHealth News and Updates

MDxHealth announces listing of 20,162,924 existing shares on Euronext Brussels following Equity Investment by MVM Partners

Press release Regulated information. 16 October 2020, 07:00 a.m. CEST

Liquid Biopsy Market Growth Rate of 23.80% by 2026 Global Industry Size, Share, Trends, COVID-19 Analysis and Technology Advancements by QIAGEN, MDxHealth, CareDx, Inc., Immucor, Inc., Menarini Silicon Biosystems, Guardant Health, Myriad Genetics

SAN FRANCISCO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Data Bridge Market Research has added a new report titled Global Liquid Biopsy Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. Global Liqu…

MDxHealth Reports Half Year 2020 Results

Conference call with Q&A today at 08:00 CET / 07:00 GMT, details provided below

MDxHealth Provides Update on Medicare Coverage for SelectMDx

Press Release  Regulated Information Inside Information August 7, 2020, 7:00 CET

MDxHealth (R):

Press Release   27 July 2020, 7:00 CET

MDxHealth Announces its Special and Extraordinary General Shareholders’ Meetings

Press release Regulated information 30 June 2020, 7:30 a.m. CEST
Show more

MDxHealth Blogs

MDxHealth Successfully Completes a EUR 25.0 Million (USD 30.4 Million)(1) Capital Increase

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW NEWS RELEASE – REGULATED INFORMATION – INSIDE INFORMATION21 January 2021, 11:30 p.…

MDxHealth Launches Capital Increase and Provides Preliminary 2020 Financial Results

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW NEWS RELEASE – REGULATED INFORMATION – INSIDE INFORMATION21 January 2021, 04:00 p.…

MDxHealth Frequently Asked Questions

  • When was MDxHealth founded?

    MDxHealth was founded in 2004.

  • Who are MDxHealth key executives?

    MDxHealth's key executives are Michael K. McGarrity, Koen Hoffman and Joseph Sollee.

  • How many employees does MDxHealth have?

    MDxHealth has 177 employees.

  • Who are MDxHealth competitors?

    Competitors of MDxHealth include Veracyte, Dadi and Longhorn Vaccines and Diagnostics.

  • Where is MDxHealth headquarters?

    MDxHealth headquarters is located at 31 Rue d'Abhooz, Herstal.

  • Where are MDxHealth offices?

    MDxHealth has offices in Herstal, Irvine and Nijmegen.

  • How many offices does MDxHealth have?

    MDxHealth has 3 offices.